Concord Biotech Ltd.

BSE: 543960 | NSE: CONCORDBIO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE338H01029 | SECTOR: Biotechnology & Medical ResearchBiotechnology & Medical Research

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Concord Biotec Concord Biotech Ltd. | BSE 1350.50 -3.55 (-0.26%) | NSE 1351.10 -1.00 (-0.07%) | Trade | Add

BSE Live

Jan 14, 16:01

1350.50 -3.55 (-0.26%)

Volume

AVERAGE VOLUME

5-Day

27,029

10-Day

14,499

30-Day

6,400

1,865

NSE Live

Jan 14, 15:46

1351.10 -1.00 (-0.07%)

Volume

AVERAGE VOLUME

5-Day

504,487

10-Day

280,124

30-Day

143,060

23,385

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Concord Biotech (in Rs. Cr.)	Mar 25	Mar 24
Per Share Ratios
Basic EPS (Rs.)	35.65	29.13
Diluted EPS (Rs.)	35.65	29.13
Cash EPS (Rs.)	40.85	34.25
Book Value [ExclRevalReserve]/Share (Rs.)	173.27	145.80
Book Value [InclRevalReserve]/Share (Rs.)	173.27	145.80
Dividend / Share(Rs.)	10.70	8.75
Revenue from Operations/Share (Rs.)	114.71	97.21
PBDIT/Share (Rs.)	52.65	44.48
PBIT/Share (Rs.)	47.45	39.36
PBT/Share (Rs.)	47.40	39.11
Net Profit/Share (Rs.)	35.65	29.13
Profitability Ratios
PBDIT Margin (%)	45.89	45.75
PBIT Margin (%)	41.36	40.48
PBT Margin (%)	41.31	40.23
Net Profit Margin (%)	31.07	29.96
Return on Networth / Equity (%)	20.57	19.97
Return on Capital Employed (%)	26.83	26.44
Return on Assets (%)	18.33	17.93
Total Debt/Equity (X)	0.00	0.00
Asset Turnover Ratio (%)	0.64	0.63
Liquidity Ratios
Current Ratio (X)	6.17	6.30
Quick Ratio (X)	4.87	4.84
Inventory Turnover Ratio (X)	5.36	0.88
Dividend Payout Ratio (NP) (%)	24.54	23.44
Dividend Payout Ratio (CP) (%)	21.42	19.94
Earnings Retention Ratio (%)	75.46	76.56
Cash Earnings Retention Ratio (%)	78.58	80.06
Valuation Ratios
Enterprise Value (Cr.)	17,536.50	15,881.24
EV/Net Operating Revenue (X)	14.61	15.62
EV/EBITDA (X)	31.84	34.13
MarketCap/Net Operating Revenue (X)	14.61	15.66
Retention Ratios (%)	75.45	76.55
Price/BV (X)	9.67	10.44
Price/Net Operating Revenue	14.61	15.66
Earnings Yield	0.02	0.02